TY  - GEN
AU  - Ding,Xiwei
AU  - Chaiteerakij,Roongruedee
AU  - Moser,Catherine D
AU  - Shaleh,Hassan
AU  - Boakye,Jeffrey
AU  - Chen,Gang
AU  - Ndzengue,Albert
AU  - Li,Ying
AU  - Zhou,Yanling
AU  - Huang,Shengbing
AU  - Sinicrope,Frank A
AU  - Zou,Xiaoping
AU  - Thomas,Melanie B
AU  - Smith,Charles D
AU  - Roberts,Lewis R
TI  - Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
SN  - 1949-2553
PY  - 2018///0117
KW  - Adamantane
KW  - analogs & derivatives
KW  - Apoptosis
KW  - drug effects
KW  - Autophagy
KW  - Bile Duct Neoplasms
KW  - drug therapy
KW  - Cell Proliferation
KW  - Cholangiocarcinoma
KW  - Drug Synergism
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - pharmacology
KW  - Phosphotransferases (Alcohol Group Acceptor)
KW  - antagonists & inhibitors
KW  - Protein Kinase Inhibitors
KW  - Pyridines
KW  - Sorafenib
KW  - Tumor Cells, Cultured
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.18632/oncotarget.7914
ER  -